menu
    • menu

    Company profile for AB Science

    NEW Drugs in Dev: 5
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AB Science was founded in 2001 by a team of scientists in order to develop new drugs targeting indications with unmet medical needs, in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. In human medicine, our masitinib pipeline is well advanced with several phase 3 studies in oncology and non-oncology diseases and promising data in Amyotrophic Lateral Sclerosis and indolent severe sys...
    AB Science was founded in 2001 by a team of scientists in order to develop new drugs targeting indications with unmet medical needs, in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. In human medicine, our masitinib pipeline is well advanced with several phase 3 studies in oncology and non-oncology diseases and promising data in Amyotrophic Lateral Sclerosis and indolent severe systemic mastocytosis. Masitinib is already commercialized in veterinary medicine and we celebrated in 2018 the 10th anniversary of the EMA marketing authorization of our product Masivet.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AB ScienceFrance Flag
    Country
    Country
    France
    Address
    Address
    3, Avenue George V 75008 PARIS
    Telephone
    Telephone
    +33 (0)1 47 20 00 14
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ab-science.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AB Science Stock Covered by Maxim Group at €4.00 Target Price
    AB Science Stock Covered by Maxim Group at €4.00 Target Price

    25 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/25/3300686/0/en/ab-science-announces-that-its-stock-continues-to-be-covered-by-maxim-group-with-a-target-price-of-4-00-per-share.html

    GLOBENEWSWIRE
    25 May 2026
    Share Share
    AB Science Reveals 2025 Revenues & Activity Update
    AB Science Reveals 2025 Revenues & Activity Update

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3294338/0/en/ab-science-reports-its-revenues-for-the-year-2025-and-provides-an-update-on-its-activities.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    AB Science Completes €3.2M Private Placement
    AB Science Completes €3.2M Private Placement

    29 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/29/3283456/0/en/ab-science-announces-the-successful-completion-of-a-eur-3-2-million-private-placement.html

    GLOBENEWSWIRE
    29 Apr 2026
    Share Share
    AB Science Finalizes Debt Renegotiation with Financial Creditors
    AB Science Finalizes Debt Renegotiation with Financial Creditors

    27 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7212457

    FIRSTWORD PHARMA
    27 Apr 2026
    Share Share
    AB Science Updates Clinical Development Program
    AB Science Updates Clinical Development Program

    16 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7182594

    FIRSTWORD PHARMA
    16 Apr 2026
    Share Share
    AB Science Identifies Plasma Biomarker For Masitinib In ALS
    AB Science Identifies Plasma Biomarker For Masitinib In ALS

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243911/0/en/AB-Science-announces-the-identification-of-a-plasma-biomarker-that-indicates-the-activity-of-masitinib-in-treating-ALS.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search